Cognition and atrial fibrillation: a neglected association?
30 November 2021, from
Council on Stroke
DISEASES OF THE AORTA, PERIPHERAL VASCULAR DISEASE, STROKE
Professor R. Hatala (Bratislava, SK)
Professor H. Diener (Essen, DE)
Professor G. Lip (Liverpool, GB)
After watching this webinar, participants will be able to:
understand the putative pathophysiological mechanism contributing to the risk of cognitive dysfunction/dementia in patients with atrial fibrillation focusing on the role of subclinical cerebral microemboli;
understand the role of new imaging techniques to visualise potential dementia substrates related to atrial fibrillation;
address the association of cognitive dysfunction, dementia and covert cerebral infarction in AF patients, which are key factors for deciding anticoagulation management; and
acquaint themselves with existing clinical evidence on the role of anticoagulation therapy in preventing dementia in patients with atrial fibrillation.
This programme is supported by Bayer AG in the form of an educational grant. The scientific programme has not been influenced in any way by its sponsor.
This webinar is designed for cardiologists, neurologists, internists, primary care physicians but also cardiologists wishing to update their scientific knowledge on the topic.
During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.
The webinar is available on PC and tablets. The use of a smartphone is not recommended.
To answer the MCQs during the live, you must allow pop-up windows.
A high-speed Internet connection is required (minimum 2 Mbps).